Showing 1 - 7 results of 7 for search 'Monika A. Davare', query time: 0.03s Refine Results
  1. 1
    Novel insight into mechanisms of ROS1 catalytic activation via loss of the extracellular domain

    Novel insight into mechanisms of ROS1 catalytic activation via loss of the extracellular domain by Kristen Jones, Clare Keddy, Chelsea Jenkins, Katelyn Nicholson, Ujwal Shinde, Monika A. Davare

    Published 2024-09-01
    Get full text
    Article
  2. 2
    Author Correction: TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancers

    Author Correction: TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancers by Rajat Thawani, Matteo Repetto, Clare Keddy, Katelyn Nicholson, Kristen Jones, Kevin Nusser, Catherine Z. Beach, Guilherme Harada, Alexander Drilon, Monika A. Davare

    Published 2024-08-01
    Get full text
    Article
  3. 3
    TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancers

    TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancers by Rajat Thawani, Matteo Repetto, Clare Keddy, Katelyn Nicholson, Kristen Jones, Kevin Nusser, Catherine Z. Beach, Guilherme Harada, Alexander Drilon, Monika A. Davare

    Published 2024-08-01
    Get full text
    Article
  4. 4
    Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors

    Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors by Sudarshan R Iyer, Kevin Nusser, Kristen Jones, Pushkar Shinde, Clare Keddy, Catherine Z Beach, Erin Aguero, Jeremy Force, Ujwal Shinde, Monika A Davare

    Published 2023-10-01
    Get full text
    Article
  5. 5
    Discovery and Validation of a Compound to Target Ewing’s Sarcoma

    Discovery and Validation of a Compound to Target Ewing’s Sarcoma by Ellie Esfandiari Nazzaro, Fahad Y. Sabei, Walter K. Vogel, Mohamad Nazari, Katelyn S. Nicholson, Philip R. Gafken, Olena Taratula, Oleh Taratula, Monika A. Davare, Mark Leid

    Published 2021-09-01
    Get full text
    Article
  6. 6
    NTRK kinase domain mutations in cancer variably impact sensitivity to type I and type II inhibitors

    NTRK kinase domain mutations in cancer variably impact sensitivity to type I and type II inhibitors by Romel Somwar, Nicolle E. Hofmann, Bryan Smith, Igor Odintsov, Morana Vojnic, Irina Linkov, Ashley Tam, Inna Khodos, Marissa S. Mattar, Elisa de Stanchina, Daniel Flynn, Marc Ladanyi, Alexander Drilon, Ujwal Shinde, Monika A. Davare

    Published 2020-12-01
    Get full text
    Article
  7. 7
    RET inhibition in novel patient-derived models of RET fusion- positive lung adenocarcinoma reveals a role for MYC upregulation

    RET inhibition in novel patient-derived models of RET fusion- positive lung adenocarcinoma reveals a role for MYC upregulation by Takuo Hayashi, Igor Odintsov, Roger S. Smith, Kota Ishizawa, Allan J. W. Liu, Lukas Delasos, Christopher Kurzatkowski, Huichun Tai, Eric Gladstone, Morana Vojnic, Shinji Kohsaka, Ken Suzawa, Zebing Liu, Siddharth Kunte, Marissa S. Mattar, Inna Khodos, Monika A. Davare, Alexander Drilon, Emily Cheng, Elisa de Stanchina, Marc Ladanyi, Romel Somwar

    Published 2021-02-01
    Get full text
    Article

Search Tools: